CVS buys Health Net’s Medicare PDP
One of the largest pharmacy benefits managers in the U.S. is about to get bigger. Health Net Inc. says it will sell its Medicare prescription-drug plan (PDP) business to CVS Caremark Corp. (CVS) for about $160 million in cash.
One of the largest pharmacy benefits managers in the U.S. is about to get bigger. Health Net Inc. says it will sell its Medicare prescription drug plan (PDP) business to CVS Caremark Corp. (CVS) for about $160 million in cash.
Health Net has approximately 400,000 Medicare PDP members in 49 states and the District of Columbia. Its annualized revenue for the Medicare PDP business is approximately $490 million. The company will continue to provide prescription drug plans as part of its Medicare Advantage plan offerings.
In November 2010, Health Net was sanctioned by the Centers for Medicare & Medicaid Services (CMS) for lack of compliance with certain Part D requirements. The sanctions were lifted in August.
The acquisition, which requires approval from CMS, is expected to close in the second quarter.
For CVS, the deal comes on the heels of steady growth following the acquisition of the Medicare PDP business of Universal American Corp. in April 2011, which more than doubled its Medicare Part D business. Also, last fall, CVS announced a partnership with Aetna to offer a co-branded Medicare PDP in 43 states and the District of Columbia.
CVS runs more than 7,300 drugstores and is one of the largest pharmacy benefits managers in the U.S. According to analysts, expanding its Medicare Part D business is attractive to the company because more aging Americans are getting their prescription drug coverage from Medicare.
Go back to the Managed Healthcare Executive eNews newsletter.
Premiums for Employer-based Health Insurance Increased by 7% in 2024, Says KFF Report
Published: October 9th 2024 | Updated: October 9th 2024The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health benefits also found that only 18% of large employers (200 employees are more) are covering the GLP-1 weight loss drugs.
Read More
Doug Chaet of Value Evolutions Discusses Value-based Payment Models, Where They Stand and More
September 29th 2022In this episode of Tuning In to the C-Suite, Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing, the status of select payment models like bundled and episodic, and more.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
We conducted our annual State of the Industry survey in the early part of November 2023. The survey had 432 respondents, of whom 56% self-reported working for a payer organization (pharmacy benefit manager, insurer or self-insured employer), 34% for a provider organization and the remainder for government or an unspecified “other” category.
Read More
